Butyrate, IL‐4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?
BioEssays · 2025-09 · 47 (9)
DOI: 10.1002/bies.70046 ↗At a glance
Übersichtsarbeit in BioEssays, published online on 2025-07-23. Written by Hiromichi Fujino. Institution: Department of Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima Universi…. Major MEDLINE topics: Receptors, Prostaglandin E, EP4 Subtype, Colorectal Neoplasms, Inflammatory Bowel Diseases, Interleukin-4. Cited 3 times so far (Crossref); 67 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Japan Society for the Promotion of Science.
Abstract (original language)
In this article, onset mechanisms of colorectal cancer and intestinal bowel diseases (IBD) are postulated to involve the aberrant expression/hyper‐activation of E‐type prostanoid 4 (EP4) receptors. Although prostaglandin E 2 and EP4 receptors are important factors for maintaining colorectal homeostasis, their mediated signaling is also considered to be involved in the etiology of severe intestinal diseases. To prevent uncontrollable activations of EP4 receptors, two safety factors are proposed: butyrate as an external safety factor and interleukin (IL)‐4 as an internal safety factor. Thus, for maintaining vulnerable colorectal homeostasis, the levels of EP4 receptors, butyrate, and IL‐4 are proposed as an important triad for protecting against development/onset risks of, at least, EP4 receptor‐mediated cancer and IBD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
ORCID profiles: Hiromichi Fujino
Funding
- Japan Society for the Promotion of Science
Cite
APA
Fujino, H. (2025). Butyrate, IL‐4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?. BioEssays, 47(9). https://doi.org/10.1002/bies.70046
Vancouver
Fujino H. Butyrate, IL‐4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?. BioEssays. 2025;47(9). doi:10.1002/bies.70046
BibTeX
@article{Fujino2025,
author = {Fujino, Hiromichi},
title = {Butyrate, IL‐4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?},
journal = {BioEssays},
year = {2025},
volume = {47},
number = {9},
doi = {10.1002/bies.70046}
}
EUVIMED